Search Results

There are 236800 results for: content related to: Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib

  1. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 12, December 2013, Pages: 1834–1841, Daisuke Miyaki, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Ayako Urabe, Keiichi Masaki, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Takashi Nakahara, Tomokazu Kawaoka, Akira Hiramatsu, Shoichi Takahashi, Masaki Ishikawa, Hideaki Kakizawa, Kazuo Awai and Kazuaki Chayama

    Version of Record online : 22 NOV 2013, DOI: 10.1111/jgh.12311

  2. You have full text access to this OnlineOpen article
    FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity

    Pharmacology Research & Perspectives

    Volume 3, Issue 5, October 2015, Dilruba Ahmed, Petra J. de Verdier, Charlotta Ryk, Oscar Lunqe, Per Stål and Jenny Flygare

    Version of Record online : 19 AUG 2015, DOI: 10.1002/prp2.171

  3. You have free access to this content
    Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2363–2374, Carlo Spirli, Carola M. Morell, Luigi Locatelli, Stefano Okolicsanyi, Cecilia Ferrero, Amy K. Kim, Luca Fabris, Romina Fiorotto and Mario Strazzabosco

    Version of Record online : 27 AUG 2012, DOI: 10.1002/hep.25872

  4. You have free access to this content
    Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice

    Hepatology

    Volume 59, Issue 4, April 2014, Pages: 1435–1447, Yunching Chen, Yuhui Huang, Thomas Reiberger, Annique M. Duyverman, Peigen Huang, Rekha Samuel, Lotte Hiddingh, Sylvie Roberge, Christina Koppel, Gregory Y. Lauwers, Andrew X. Zhu, Rakesh K. Jain and Dan G. Duda

    Version of Record online : 18 FEB 2014, DOI: 10.1002/hep.26790

  5. You have free access to this content
    Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib – the role of extracellular signal-regulated kinase counteraction

    The FEBS Journal

    Volume 278, Issue 18, September 2011, Pages: 3494–3507, Irena Manov, Yulia Pollak, Rinata Broneshter and Theodore C. Iancu

    Version of Record online : 5 SEP 2011, DOI: 10.1111/j.1742-4658.2011.08271.x

  6. You have free access to this content
    Nuclear factor kappa B–mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice

    Hepatology

    Volume 62, Issue 2, August 2015, Pages: 534–545, Jessica Lo, Eunice Yuen Ting Lau, Rachel Hiu Ha Ching, Bowie Yik Ling Cheng, Mark Kin Fai Ma, Irene Oi Lin Ng and Terence Kin Wah Lee

    Version of Record online : 3 JUN 2015, DOI: 10.1002/hep.27859

  7. You have free access to this content
    EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib

    International Journal of Cancer

    Volume 131, Issue 12, 15 December 2012, Pages: 2961–2969, Zakaria Ezzoukhry, Christophe Louandre, Eric Trécherel, Corinne Godin, Bruno Chauffert, Sébastien Dupont, Momar Diouf, Jean-Claude Barbare, Jean-Claude Mazière and Antoine Galmiche

    Version of Record online : 30 APR 2012, DOI: 10.1002/ijc.27604

  8. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  9. You have full text access to this Open Access content
    Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 8b, August 2009, Pages: 2673–2683, Hung Huynh, Van Chanh Ngo, Heng Nung Koong, Donald Poon, Su Pin Choo, Choon Hua Thng, Pierce Chow, Hock Soo Ong, Alexander Chung and Khee Chee Soo

    Version of Record online : 11 FEB 2009, DOI: 10.1111/j.1582-4934.2009.00692.x

  10. You have free access to this content
    Sorafenib rechallenge in patients with metastatic renal cell carcinoma

    BJU International

    Volume 110, Issue 6b, September 2012, Pages: E228–E234, Masahiro Nozawa, Yutaka Yamamoto, Takafumi Minami, Nobutaka Shimizu, Yuji Hatanaka, Hidenori Tsuji and Hirotsugu Uemura

    Version of Record online : 14 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10905.x

  11. You have free access to this content
    Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma

    Hepatology

    Volume 57, Issue 5, May 2013, Pages: 1847–1857, Yingjian Liang, Tongsen Zheng, Ruipeng Song, Jiabei Wang, Dalong Yin, Luoluo Wang, Haitao Liu, Lantian Tian, Xiang Fang, Xianzhi Meng, Hongchi Jiang, Jiaren Liu and Lianxin Liu

    Version of Record online : 14 MAR 2013, DOI: 10.1002/hep.26224

  12. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  13. You have free access to this content
    Effects of Antitumor Drug Sorafenib on Chick Embryo Development

    The Anatomical Record

    Volume 298, Issue 7, July 2015, Pages: 1271–1281, Yi-Sen Cheng, Xiao-Yu Wang, Guang Wang, Yan Li, Yue-Lei Chen, Man-li Chuai, Kenneth Ka Ho Lee, Xiao-Yan Ding and Xue-song Yang

    Version of Record online : 17 APR 2015, DOI: 10.1002/ar.23155

  14. You have full text access to this OnlineOpen article
    Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 430–441, Eva Juengel, Dana Kim, Jasmina Makarević, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp and Roman A. Blaheta

    Version of Record online : 2 DEC 2014, DOI: 10.1111/jcmm.12471

  15. You have free access to this content
    Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

    Hepatology

    Volume 53, Issue 5, May 2011, Pages: 1708–1718, Yue-Lei Chen, Jing Lv, Xiao-Lei Ye, Ming-Yu Sun, Qin Xu, Cheng-Hai Liu, Li-Hua Min, Hui-Ping Li, Ping Liu and Xiaoyan Ding

    Version of Record online : 22 APR 2011, DOI: 10.1002/hep.24254

  16. You have free access to this content
    Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2448–2458, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim, Teng-Yu Lee and Yee Chao

    Version of Record online : 28 NOV 2012, DOI: 10.1002/ijc.27925

  17. Sorafenib-induced premalignant and malignant skin lesions

    International Journal of Dermatology

    Volume 50, Issue 4, April 2011, Pages: 396–402, Victoria L. Williams, Philip R. Cohen and David J. Stewart

    Version of Record online : 18 MAR 2011, DOI: 10.1111/j.1365-4632.2010.04822.x

  18. You have full text access to this OnlineOpen article
    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1434–1444, Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. van den Heuvel, Jos Jonkers, Egbert F. Smit and René Bernards

    Version of Record online : 8 AUG 2014, DOI: 10.1002/ijc.29113

  19. You have free access to this content
    A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1190–1199, Joaquim Bellmunt, Tim Eisen, Cezary Szczylik, Peter Mulders and Camillo Porta

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09829.x

  20. You have free access to this content
    ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21(CIP1/WAF1) in human cancer cells

    British Journal of Pharmacology

    Volume 171, Issue 13, July 2014, Pages: 3182–3195, Jingru Li, Yicheng Chen, Jiali Wan, Xin Liu, Chunrong Yu and Wenhua Li

    Version of Record online : 10 JUN 2014, DOI: 10.1111/bph.12659